Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

替格瑞洛

Tier B · 提前布局

Ticagrelor · 2029 年到期全部品种 →

阿斯利康
原研
2010
首批上市
2029
到期年(公开口径)
$1.59B ▲
峰值销售
化学药
类型

靶点P2RY12

商品名Brilinta、Possia、倍林达、Brilinta/Brilique、Brilique

适应症(已批准)中风、急性冠脉综合征、心肌梗塞、外周血管疾病

各地区研发/上市状态

美国
批准上市
2011-07-20
欧盟
批准上市
2010-12-03
中国
批准上市
2012-11-22
日本
批准上市
2016-09-28

合成路线与中间体5 routes

原研路线 × 1优化路线(非专利)× 4工艺路线 × 0

路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。

原研Route 1步骤 9 · 总收率 /
合成路线与中间体 Route 1
编号CAS 号中间体名称
TICA-001145783-14-8在售4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
TICA-002155899-66-4在售(3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol
TICA-003220241-59-8在售(3aR,4S,6R,6aS)-6-((6-chloro-5-nitro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol
TICA-004220241-60-1在售(3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol
TICA-005220241-61-2在售(3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol
TICA-006274693-22-0在售(3aR,4S,6R,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-ol
TICA-00788016-31-3在售methyl 2-(((trifluoromethyl)sulfonyl)oxy)acetate
TICA-008274693-23-1在售methyl 2-(((3aR,4S,6R,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
TICA-009274693-24-2在售methyl 2-(((3aR,4S,6R,6aS)-6-(7-bromo-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
TICA-010220352-38-5在售(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine
TICA-011274693-25-3在售methyl 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
TICA-01230472-97-0在售potassium sodium (2R,3R)-2,3-dihydroxysuccinate
TICA-013274693-26-4在售2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol
TICA-01460410-16-4在售(1R,4S)-4-hydroxycyclopent-2-en-1-yl acetate
TICA-01551779-32-9在售-
TICA-016220241-57-6在售-
TICA-0177529-22-8在售4-methylmorpholine 4-oxide
TICA-018220241-58-7在售-
TICA-01977-76-9在售2,2-dimethoxypropane
优化Route 2步骤 9 · 总收率 19 mg
合成路线与中间体 Route 2
编号CAS 号中间体名称
TICA-010220352-38-5在售(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine
TICA-013274693-26-4在售2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol
TICA-0202171459-69-9在售6-hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one
TICA-021107-08-4在售1-iodopropane
TICA-022145783-12-6在售2-(propylthio)pyrimidine-4,6-diol
TICA-023106-49-0在售p-toluidine
TICA-024376608-72-9在售(E)-2-(propylthio)-5-(p-tolyldiazenyl)pyrimidine-4,6-diol
TICA-025376608-73-0在售(E)-4,6-dichloro-2-(propylthio)-5-(p-tolyldiazenyl)pyrimidine
TICA-0261415806-23-3在售4,6-dichloro-2-(propylthio)-5-(2-(p-tolyl)hydrazinyl)pyrimidine
TICA-027145783-15-9在售4,6-dichloro-2-(propylthio)pyrimidin-5-amine
TICA-028274693-55-9在售2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol
TICA-029376608-74-1在售2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol
TICA-030376608-75-2在售2-(((3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol
优化Route 3步骤 7 · 总收率 /
合成路线与中间体 Route 3
编号CAS 号中间体名称
TICA-010220352-38-5在售(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine
TICA-03134036-07-2在售3,4-difluorobenzaldehyde
TICA-032141-82-2在售malonic acid
TICA-033112897-97-9在售(E)-3-(3,4-difluorophenyl)acrylic acid
TICA-034376608-66-1在售(E)-3-(3,4-difluorophenyl)acryloyl chloride
TICA-03589-78-1在售(1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol
TICA-036376608-67-2在售(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (E)-3-(3,4-difluorophenyl)acrylate
TICA-037376608-68-3在售(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate
TICA-038220352-36-3在售(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylic acid
TICA-039378236-67-0在售(1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carbonyl azide
优化Route 4步骤 5 · 总收率 192 mg
合成路线与中间体 Route 4
编号CAS 号中间体名称
TICA-027145783-15-9在售4,6-dichloro-2-(propylthio)pyrimidin-5-amine
TICA-0401068-90-2在售diethyl 2-acetamidomalonate
TICA-04162-56-6在售thiourea
TICA-0421549834-16-3在售sodium 5-acetamido-4,6-dihydroxypyrimidine-2-thiolate
TICA-043133030-24-7在售N-(4,6-dihydroxy-2-mercaptopyrimidin-5-yl)acetamide
TICA-044106-94-5在售1-bromopropane
TICA-0451549834-56-1在售N-(4,6-dihydroxy-2-(propylthio)pyrimidin-5-yl)acetamide
TICA-0461549834-66-3在售5-amino-2-(propylthio)pyrimidine-4,6-diol hydrochloride
优化Route 5步骤 9 · 总收率 0.48 g
合成路线与中间体 Route 5
编号CAS 号中间体名称
TICA-001145783-14-8在售4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
TICA-010220352-38-5在售(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine
TICA-047866551-95-3在售ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
TICA-0481612796-22-1在售ethyl 2-(((1S,2S,3S,4R)-4-(((benzyloxy)carbonyl)amino)-2,3-dihydroxycyclopentyl)oxy)acetate
TICA-0491612796-23-2在售ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2-oxotetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate
TICA-0501612796-24-3在售benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2-oxotetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)carbamate
TICA-0511612796-25-4在售(3aS,4R,6S,6aR)-4-amino-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one
TICA-0521612796-35-6在售(3aS,4R,6S,6aR)-4-((6-chloro-5-nitro-2-(propylthio)pyrimidin-4-yl)amino)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one
TICA-0531482484-91-2在售(3aS,4R,6S,6aR)-4-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one
TICA-0541612796-36-7在售(3aS,4R,6S,6aR)-4-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one
TICA-0551612796-37-8在售(3aS,4R,6S,6aR)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-6-(2-hydroxyethoxy)tetrahydro-4H-cyclopenta[d][1,3]dioxol-2-one

常见问题(FAQ)

替格瑞洛的适应症有哪些?

已批准的适应症包括:中风、急性冠脉综合征、心肌梗塞、外周血管疾病。

替格瑞洛的专利什么时候到期?

按公开口径,替格瑞洛的专利到期年为 2029 年。

替格瑞洛有几条合成路线?

本站收录 5 条合成路线,最短路线 5 步、总收率 192 mg。每条路线的中间体均带登记编号与 CAS 号。

替格瑞洛的关键中间体在哪里可以采购?

替格瑞洛的多条路线中间体已挂接 CAS 档案,其中 55 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。

如何获取替格瑞洛中间体的报价?

在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。

数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24